Free Trial

JPMorgan Chase & Co.'s Rating of Novozymes A/S on 3/26/2019

On March 26, 2019, JPMorgan Chase & Co. updated its outlook on Novozymes A/S (OTCMKTS:NVZMF) with the action "Reiterated Rating", keeping a "Underweight" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from JPMorgan Chase & Co.

DateCompanyAction
10/20/2025
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
Upgrade
10/20/2025
The Charles Schwab Corporation stock logo
SCHW
Charles Schwab
Boost Price Target
10/20/2025
Commercial Metals Company stock logo
CMC
Commercial Metals
Boost Price Target
10/20/2025
CSX Corporation stock logo
CSX
CSX
Boost Price Target
10/20/2025
Hershey Company (The) stock logo
HSY
Hershey
Boost Price Target
10/20/2025
Talen Energy Corporation stock logo
TLN
Talen Energy
Boost Price Target
More Ratings From JPMorgan Chase & Co.